SCHEMBL15528879

SCHEMBL15528879

O=C(Nc1cc[c]cc1)C1CCNCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 1/20 0.52
FLT3 P36888 1/20 0.51
ULK1 O75385 1/20 0.50
NAMPT P43490 2/20 0.49
LMNA P02545 4/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
HPGD P15428 2/20 0.47
PTPN1 P18031 2/20 0.47
GAA P10253 2/20 0.46
MAPT P10636 2/20 0.46
GFER P55789 1/20 0.46
SNCA P37840 1/20 0.45
DYRK1A Q13627 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
GLA P06280 1/20 0.45
USP2 O75604 1/20 0.45
HTT P42858 1/20 0.45
F10 P00742 2/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4573856 0.90 ULK1 (0.46) SIRT2FLT3ULK1NAMPTLMNA
SCHEMBL883845 0.88 NAMPT (0.61) NAMPTLMNAMEN1KMT2AHPGD
SCHEMBL7044145 0.84 PTPN1 (0.61) NAMPTLMNAMEN1KMT2AHPGD
SCHEMBL1448057 0.84 PTPN1 (0.66) NAMPTLMNAMEN1KMT2AHPGD
SCHEMBL4141969 0.83 HPGD (0.69) SIRT2ULK1LMNAMEN1KMT2A
SCHEMBL693169 0.83 PTPN1 (0.69) NAMPTLMNAMEN1KMT2AHPGD
SCHEMBL2386265 0.81 SIRT2 (0.48) SIRT2FLT3ULK1LMNAMEN1
SCHEMBL10151574 0.81 SNCA (0.58) SIRT2FLT3ULK1NAMPTLMNA
Hydrochloric Acid SCHEMBL8508299 0.81 HPGD (0.67) SIRT2LMNAMEN1KMT2AHPGD
SCHEMBL18395563 0.80 KMT2A (0.58) SIRT2ULK1NAMPTLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150141410-A1 GPR17 Receptor Modulators UNIVERSITA' DEGLI STUDI DI MILANO (IT) 2015-05-21 US claimed
EP-2850068-A1 GPR17 RECEPTOR MODULATORS. Universita' degli Studi di Milano (IT) 2015-03-25 EP claimed
WO-2013167177-A1 GPR17 RECEPTOR MODULATORS. UNIVERSITA' DEGLI STUDI DI MILANO (IT) 2013-11-14 WO claimed
EP-2850068-B1 N-(phenyl)-2-[[3-(phenyl)-1H-1,2,4-triazol-5-yl]thio]-acetamide derivatives and related compounds as G protein coupled receptor 17 (GPCR17) modulators for use in the treatment of neuro-degenerative diseases UNIV DEGLI STUDI MILANO (IT) 2019-05-29 EP disclosed
US-9879030-B2 GPR17 receptor modulators UNIVERSITA′ DEGLI STUDI DI MILANO (IT) 2018-01-30 US disclosed
US-20150141410-A1 GPR17 Receptor Modulators UNIVERSITA' DEGLI STUDI DI MILANO (IT) 2015-05-21 US disclosed
EP-2850068-A1 GPR17 RECEPTOR MODULATORS. Universita' degli Studi di Milano (IT) 2015-03-25 EP disclosed
WO-2013167177-A1 GPR17 RECEPTOR MODULATORS. UNIVERSITA' DEGLI STUDI DI MILANO (IT) 2013-11-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150141410-A1 GPR17 Receptor Modulators GPR65, GPR27, GPR17 SIRT2 882/4885FLT3 3393/4885ULK1 985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.